Actinomycetes of the genus Rhodococcus (class Actinomycetia) are dominant dwellers of biotopes with anthropogenic load. They serve as a natural system of primary response to xenobiotics in open ecosystems, initiate defensive responses in the presence of pollutants, and are regarded as ideal agents capable of transforming and degrading pharmaceuticals. Here, the ability of selected Rhodococcus strains to co-metabolize nonsteroidal anti-inflammatory drugs (ibuprofen, meloxicam, and naproxen) and information on the protective mechanisms of rhodococci against toxic effects of pharmaceuticals, individually or in a mixture, have been demonstrated. For the first time, R. ruber IEGM 439 provided complete decomposition of 100 mg/L meloxicam after seven days. It was shown that versatile cellular modifications occurring at the early development stages of nonspecific reactions of Rhodococcus spp. in response to separate and combined effects of the tested pharmaceuticals included changes in electrokinetic characteristics and catalase activity; transition from unicellular to multicellular life forms accompanied by pronounced morphological abnormalities; changes in the average size of vegetative cells and surface area-to-volume ratio; and the formation of linked cell assemblages. The obtained data are considered as adaptation mechanisms in rhodococci, and consequently their increased resistance to separate and combined effects of ibuprofen, meloxicam, and naproxen.
Bacteria of the genus Rhodococcus are degraders of various ecotoxicants, including pharmaceuticals, yet their activity against ketoprofen—a non-steroidal anti-inflammatory drug (NSAID) frequently detected in aquatic environments—remains poorly explored. To address this gap, we assessed the tolerance and removal of ketoprofen across Rhodococcus strains from the Regional Specialised Collection of Alkanotrophic Microorganisms (official acronym IEGM, WFCC number 285). All 175 strains tolerated ketoprofen at minimum inhibitory concentrations far above reported environmental levels. Two particularly resilient strains, R. erythropolis IEGM 712 and R. qingshengii IEGM 746, sustained growth in ketoprofen-supplemented medium. Transmission electron microscopy (TEM) examinations showed that most cells preserved structural integrity and morphology, while energy dispersive X-ray spectroscopy and elemental mapping showed maintenance of K+ homeostasis. Over 14 days of cultivation in the mineral medium with n-hexadecane, these two strains removed 40–58% of ketoprofen. Exposure to ketoprofen altered cellular morphometry and surface charge (ζ-potential) and led to the formation of by-products with a predicted lower ecotoxicity than the parent compound. These findings underscore the potential of Rhodococcus strains for the bioremediation of ketoprofen.